Peijia Medical Executive and Leadership Team

Michael Zhang, the Chairman & Chief Executive Officer at Peijia Medical, directs the overarching corporate strategy and long-term vision for structural heart and neurovascular intervention markets. By aligning internal research initiatives with global clinical needs, the Chairman & Chief Executive Officer ensures the organization maintains a competitive edge in high-end medical device manufacturing. Michael Zhang oversees the expansion of product portfolios, specifically targeting aortic and mitral valve advancements to address complex cardiovascular conditions. This leadership role involves constant engagement with the Board to secure sustainable growth and operational excellence across international markets. Through rigorous oversight of corporate governance and strategic partnerships, the executive drives the company toward becoming a premier provider of life-saving medical solutions. By prioritizing patient safety and technological accessibility, the leadership team fosters a culture of innovation that directly impacts the quality of life for patients requiring specialized cardiovascular care.

Leo Tsai, the Chief Financial Officer at Peijia Medical, governs the financial health and capital allocation strategies necessary for sustaining high-end medical device development. Managing the fiscal planning and investor relations, the Chief Financial Officer ensures that resources flow effectively into research and development for tricuspid valves and neurovascular intervention products. Leo Tsai oversees the financial reporting processes, maintaining transparency and compliance with international regulatory standards. This leadership role involves analyzing market trends to guide investment decisions, ensuring the company remains well-positioned for long-term growth in the competitive structural heart disease sector. By optimizing the capital structure and managing financial risks, the executive provides the stability required for continuous innovation. Tsai works closely with the Board to communicate financial performance and strategic milestones, ensuring that every dollar invested contributes directly to the company's objective of improving patient quality of life through superior medical technology.

Karl Pan, the Chief Operating Officer at Peijia Medical, manages the daily execution of manufacturing processes and supply chain logistics for structural heart and neurovascular products. Overseeing the production facilities, the Chief Operating Officer ensures that all medical devices meet stringent quality standards before reaching hospitals and healthcare providers. Karl Pan coordinates cross-functional teams to optimize operational efficiency, reducing lead times for critical surgical accessories and intervention tools. This role involves monitoring regional market demands to adjust production capacity, particularly across the expansive Asian and emerging international markets. By streamlining internal workflows and implementing advanced manufacturing protocols, the executive supports the company's mission to provide accessible medical solutions. Pan maintains close collaboration with the leadership team to ensure that operational output aligns with the broader strategic goals of the organization, ultimately securing the reliable delivery of essential medical technology to clinical environments worldwide.

JianFong Tan, the Chief Technology Officer at Peijia Medical, architects the technical roadmap and research initiatives for next-generation structural heart and neurovascular devices. Overseeing the engineering teams, the Chief Technology Officer drives the development of innovative aortic and mitral valve technologies that define the company's market position. JianFong Tan manages the integration of advanced materials and design methodologies to ensure that all products offer safe and effective solutions for complex cardiovascular interventions. This role involves collaborating with clinical experts to translate medical requirements into functional, high-performance devices. By fostering a culture of technical excellence, the executive ensures that the company remains at the forefront of medical device innovation. Tan monitors global technological advancements to identify opportunities for product enhancement, ensuring that the organization consistently delivers cutting-edge tools to healthcare providers. Through this technical leadership, the executive directly supports the company's mission to improve patient outcomes through superior engineering.